242 related articles for article (PubMed ID: 23665803)
1. Uncertainty of testing methods--what do we (want to) know?
Paparella M; Daneshian M; Hornek-Gausterer R; Kinzl M; Mauritz I; Mühlegger S
ALTEX; 2013; 30(2):131-44. PubMed ID: 23665803
[TBL] [Abstract][Full Text] [Related]
2. Developing alternatives to systemic toxicity testing approaches.
von Aulock S
ALTEX; 2012; 29(1):1. PubMed ID: 22408846
[No Abstract] [Full Text] [Related]
3. Towards an integrated in vitro strategy for repeated dose toxicity testing.
Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
[No Abstract] [Full Text] [Related]
4. Validation of innovative technologies and strategies for regulatory safety assessment methods: challenges and opportunities.
Stokes WS; Wind M
ALTEX; 2010; 27(3):87-95. PubMed ID: 21113563
[TBL] [Abstract][Full Text] [Related]
5. Aligning the 3Rs with new paradigms in the safety assessment of chemicals.
Burden N; Mahony C; Müller BP; Terry C; Westmoreland C; Kimber I
Toxicology; 2015 Apr; 330():62-6. PubMed ID: 25932488
[TBL] [Abstract][Full Text] [Related]
6. Validation of alternative methods for toxicity testing.
Bruner LH; Carr GJ; Curren RD; Chamberlain M
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):477-84. PubMed ID: 9599695
[TBL] [Abstract][Full Text] [Related]
7. Working in partnership to advance the 3Rs in toxicity testing.
Holmes AM; Creton S; Chapman K
Toxicology; 2010 Jan; 267(1-3):14-9. PubMed ID: 19903508
[TBL] [Abstract][Full Text] [Related]
8. Adverse Outcome Pathways can drive non-animal approaches for safety assessment.
Burden N; Sewell F; Andersen ME; Boobis A; Chipman JK; Cronin MT; Hutchinson TH; Kimber I; Whelan M
J Appl Toxicol; 2015 Sep; 35(9):971-5. PubMed ID: 25943792
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
Beken S; Kasper P; van der Laan JW
Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
[TBL] [Abstract][Full Text] [Related]
10. Biostatistical methods for the validation of alternative methods for in vitro toxicity testing.
Edler L; Ittrich C
Altern Lab Anim; 2003 Jun; 31 Suppl 1():5-41. PubMed ID: 15595899
[TBL] [Abstract][Full Text] [Related]
11. Uncertainties of testing methods: What do we (want to) know about carcinogenicity?
Paparella M; Colacci A; Jacobs MN
ALTEX; 2017; 34(2):235-252. PubMed ID: 27776202
[TBL] [Abstract][Full Text] [Related]
12. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
[TBL] [Abstract][Full Text] [Related]
13. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
[TBL] [Abstract][Full Text] [Related]
14. The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.
Balls M; Amcoff P; Bremer S; Casati S; Coecke S; Clothier R; Combes R; Corvi R; Curren R; Eskes C; Fentem J; Gribaldo L; Halder M; Hartung T; Hoffmann S; Schectman L; Scott L; Spielmann H; Stokes W; Tice R; Wagner D; Zuang V;
Altern Lab Anim; 2006 Dec; 34(6):603-20. PubMed ID: 17266393
[No Abstract] [Full Text] [Related]
15. Is there a need in regulatory toxicity testing for evaluating chemicals at doses eliciting general toxicity?
Chahoud I; Grote K
Toxicology; 2016 Jul; 363-364():46-7. PubMed ID: 27430607
[No Abstract] [Full Text] [Related]
16. An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes.
Gissi A; Gadaleta D; Floris M; Olla S; Carotti A; Novellino E; Benfenati E; Nicolotti O
ALTEX; 2014; 31(1):23-36. PubMed ID: 24247988
[TBL] [Abstract][Full Text] [Related]
17. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
[TBL] [Abstract][Full Text] [Related]
18. Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing.
Törnqvist E; Annas A; Granath B; Jalkesten E; Cotgreave I; Öberg M
PLoS One; 2014; 9(7):e101638. PubMed ID: 25054864
[TBL] [Abstract][Full Text] [Related]
19. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
Rogiers V
Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
[No Abstract] [Full Text] [Related]
20. Validation is a key theme in this issue of ALTEX.
von Aulock S
ALTEX; 2011; 28(1):1. PubMed ID: 21404727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
